Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2019.Feb.20

Clearance of Adagloxad Simolenin (OBI-822) for a Phase III clinical study by Ministry of Health of Ukraine

2019.Feb.13

Clarification on the collaborative publication by OBI Pharma Inc. and Academia Sinica

2019.Jan.03

OBI Pharma Inc. to attend The 37th Annual J.P. Morgan Healthcare Conference

2018.Dec.28

Company Chairman Mr. Michael N. Chang not guilty for the prosecution by Taiwan Shilin District Court

2018.Dec.19

OBI Pharma Inc. to attend 2019 investor conference hosted by Yuanta

2018.Dec.03

OBI Pharma Inc. to attend the Citi's 2018 Global Healthcare Conference

2018.Nov.30

Announcement of the resolution of the board of directors of the company to issue common shares through rights offering

2018.Nov.23

OBI Pharma Inc. to attend the 2018 Asia Pacific Healthcare Forum, hosted by Goldman Sachs

2018.Nov.23

Clarification on the news article by Up Media and other media groups

2018.Nov.21

OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer

News

Latest News

Events

Latest events